New Research: Key Drivers of Growth for Ashford Hospitality Trust, Southwest Gas, Stoneridge, Ionis Pharmaceuticals, Alder BioPharmaceuticals, and Robert Half International — Factors of Influence, Major Initiatives and Sustained Production


NEW YORK, Feb. 23, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Ashford Hospitality Trust Inc (NYSE:AHT), Southwest Gas Corporation (NYSE:SWX), Stoneridge, Inc. (NYSE:SRI), Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), and Robert Half International Inc. (NYSE:RHI), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

AHT DOWNLOAD: http://Fundamental-Markets.com/register/?so=AHT
SWX DOWNLOAD:
http://Fundamental-Markets.com/register/?so=SWX
SRI DOWNLOAD:
http://Fundamental-Markets.com/register/?so=SRI
IONS DOWNLOAD:
http://Fundamental-Markets.com/register/?so=IONS
ALDR DOWNLOAD:
http://Fundamental-Markets.com/register/?so=ALDR
RHI DOWNLOAD:
http://Fundamental-Markets.com/register/?so=RHI

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Ashford Hospitality Trust Inc (NYSE:AHT), Southwest Gas Corporation (NYSE:SWX), Stoneridge, Inc. (NYSE:SRI), Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), and Robert Half International Inc. (NYSE:RHI) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed February 21st, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

ASHFORD HOSPITALITY TRUST INC (AHT) REPORT OVERVIEW

Ashford Hospitality Trust's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Ashford Hospitality Trust reported revenue of $353.33MM vs $371.93MM (down 5.00%) and basic earnings per share -$0.40 vs -$0.37. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Ashford Hospitality Trust reported revenue of $1,492.04MM vs $1,336.97MM (up 11.60%) and basic earnings per share -$0.95 vs $2.43. Ashford Hospitality Trust is expected to report earnings on March 1st, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.16. The estimated EPS forecast for the next fiscal year is $1.40 and is expected to report on March 1st, 2018.

To read the full Ashford Hospitality Trust Inc (AHT) report, download it here: http://Fundamental-Markets.com/register/?so=AHT

-----------------------------------------

SOUTHWEST GAS CORPORATION (SWX) REPORT OVERVIEW

Southwest Gas' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Southwest Gas reported revenue of $593.15MM vs $539.97MM (up 9.85%) and basic earnings per share $0.21 vs $0.05 (up 320.00%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Southwest Gas reported revenue of $2,460.49MM vs $2,463.63MM (down 0.13%) and basic earnings per share $3.20 vs $2.94 (up 8.84%). Southwest Gas is expected to report earnings on February 26th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $1.37. The estimated EPS forecast for the next fiscal year is $3.59 and is expected to report on February 26th, 2018.

To read the full Southwest Gas Corporation (SWX) report, download it here: http://Fundamental-Markets.com/register/?so=SWX

-----------------------------------------

STONERIDGE, INC. (SRI) REPORT OVERVIEW

Stoneridge's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Stoneridge reported revenue of $203.58MM vs $173.85MM (up 17.10%) and basic earnings per share $0.29 vs $0.37 (down 21.62%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Stoneridge reported revenue of $695.98MM vs $644.81MM (up 7.93%) and basic earnings per share $2.79 vs $0.83 (up 236.14%). Stoneridge is expected to report earnings on February 28th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.34. The estimated EPS forecast for the next fiscal year is $1.66 and is expected to report on February 28th, 2018.

To read the full Stoneridge, Inc. (SRI) report, download it here: http://Fundamental-Markets.com/register/?so=SRI

-----------------------------------------

IONIS PHARMACEUTICALS, INC. (IONS) REPORT OVERVIEW

Ionis Pharmaceuticals' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Ionis Pharmaceuticals reported revenue of $120.91MM vs $110.93MM (up 9.00%) and basic earnings per share $0.00 vs $0.06. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Ionis Pharmaceuticals reported revenue of $346.62MM vs $283.70MM (up 22.18%) and basic earnings per share -$0.72 vs -$0.74. Ionis Pharmaceuticals is expected to report earnings on February 27th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.33. The estimated EPS forecast for the next fiscal year is $0.35 and is expected to report on February 27th, 2018.

To read the full Ionis Pharmaceuticals, Inc. (IONS) report, download it here: http://Fundamental-Markets.com/register/?so=IONS

-----------------------------------------

ALDER BIOPHARMACEUTICALS, INC. (ALDR) REPORT OVERVIEW

Alder BioPharmaceuticals' Recent Financial Performance

For the twelve months ended December 31st, 2016 vs December 31st, 2015, Alder BioPharmaceuticals reported revenue of $0.11MM vs $0.00MM and basic earnings per share -$3.23 vs -$2.11. Alder BioPharmaceuticals is expected to report earnings on February 26th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.97. The estimated EPS forecast for the next fiscal year is -$3.90 and is expected to report on February 26th, 2018.

To read the full Alder BioPharmaceuticals, Inc. (ALDR) report, download it here: http://Fundamental-Markets.com/register/?so=ALDR

-----------------------------------------

ROBERT HALF INTERNATIONAL INC. (RHI) REPORT OVERVIEW

Robert Half International's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Robert Half International reported revenue of $1,346.28MM vs $1,265.07MM (up 6.42%) and basic earnings per share $0.38 vs $0.61 (down 37.70%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Robert Half International reported revenue of $5,266.79MM vs $5,250.40MM (up 0.31%) and basic earnings per share $2.34 vs $2.68 (down 12.69%). Robert Half International is expected to report earnings on April 19th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.62. The estimated EPS forecast for the next fiscal year is $3.53 and is expected to report on January 29th, 2019.

To read the full Robert Half International Inc. (RHI) report, download it here: http://Fundamental-Markets.com/register/?so=RHI

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.